Some immunotherapy treatments can cause immune cell associated neurotoxicity syndrome (ICANS). Find out more about it and the treatment you might have.
Mitigating a TDP-43 proteinopathy by targeting ataxin-2 using RNA-targeting CRISPR effector proteins
The TDP-43 proteinopathies, which include amyotrophic lateral sclerosis and frontotemporal dementia, are a devastating group of neurodegenerative disorders that are characterized by the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results